Evidence map›Paper›PMID 33658353›Full record

ArticleScience translational medicine2021

BMPR1A maintains skeletal stem cell properties in craniofacial development and craniosynostosis.

Takamitsu Maruyama, Ronay Stevens, Alan Boka, Laura DiRienzo, Connie Chang, Hsiao-Man Ivy Yu, Katsuhiko Nishimori, Clinton Morrison, Wei Hsu

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Bridging skeletal stem cell diversity and human skeletal modeling.Journal of bone and mineral metabolism · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. [Advances in the Study of Calvarial Stem Cells].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Review
  15. Article
  16. Review
  17. A Novel Missense Variant ofHuman mutation · 2025
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Takamitsu MaruyamaCenter for Oral Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-7322-8821
Ronay StevensCenter for Oral Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0003-0837-1650
Alan BokaCenter for Oral Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0002-2696-6087
Laura DiRienzoCenter for Oral Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-5707-1115
Connie ChangCenter for Oral Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0002-0462-8941
Hsiao-Man Ivy YuCenter for Oral Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Katsuhiko NishimoriDepartment of Bioregulation and Pharmacological Medicine and Department of Obesity and Internal Inflammation, Fukushima Medical University, Fukushima City 960-1295, Japan.
Clinton MorrisonDepartment of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA.
Wei HsuCenter for Oral Biology, University of Rochester Medical Center, Rochester, NY 14642, USA. wei_hsu@urmc.rochester.edu wei_hsu@icloud.com.ORCID 0000-0001-6738-6030
University of Rochester Medical Center · USFukushima Medical University · JP

Funding

GENETIC REGULATORY NETWORK IN CRANIOFACIAL DEVELOPMENTR01DE015654 · NIDCR · UNIVERSITY OF ROCHESTER · PI Wei Hsu · 2006 to 2026
$8.2M
Stem cells for craniofacial bone repair and regenerationR01DE026936 · NIDCR · UNIVERSITY OF ROCHESTER · PI HSU, WEI · 2018 to 2022
$2.9M
NIDCR NIH HHS R01 DE015654NIDCR NIH HHS R01 DE026936
6 · The paper itself

Abstract

Skeletal stem cells from the suture mesenchyme, which are referred to as suture stem cells (SuSCs), exhibit long-term self-renewal, clonal expansion, and multipotency. These SuSCs reside in the suture midline and serve as the skeletal stem cell population responsible for calvarial development, homeostasis, injury repair, and regeneration. The ability of SuSCs to engraft in injury site to replace the damaged skeleton supports their potential use for stem cell-based therapy. Here, we identified BMPR1A as essential for SuSC self-renewal and SuSC-mediated bone formation. SuSC-specific disruption of

Indexed as

CraniosynostosesAnimalsBone Morphogenetic Protein Receptors, Type ICell DifferentiationMiceOsteogenesisSkullStem CellsBmpr1a protein, mouseBone Morphogenetic Protein Receptors, Type I

Identifiers

PMID33658353
PMCPMC8590202
OpenAlexW3134413673

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.